Study finds HDFN patients with previous transfusions at higher risk in future pregnancies
A study found that HDFN patients who underwent an intrauterine transfusion have an increased risk of needing another in their next pregnancies.
A study found that HDFN patients who underwent an intrauterine transfusion have an increased risk of needing another in their next pregnancies.
A noninvasive screening program in Switzerland has shown promising results, allowing preventative measures against hemolytic disease of the fetus and newborn (HDFN) only in pregnancies that require it.
A recently published report shows a combination of intensive treatment with ultraviolet light (phototherapy) and injected human antibodies (immunoglobulin) was successful in an infant with HDFN.
The antibodies responsible for hemolytic disease of the fetus and newborn (HDFN) could be transmitted to newborns through breast milk, case studies show.
A small study shows a new noninvasive test could enable the diagnosis of hemolytic disease of the fetus and newborn (HDFN) in the third trimester.